IGFBP5 and ovarian carcinoma: We examined the IGFBP5 expression level in several ovarian cancer cell lines using reverse transcription PCR (RT-PCR) and found that it was downregulated in cancer cell lines relative to levels in the IOSE normal ovarian cell line (Fig. 1C).